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ABSTRACT A strain of luminous bacteria, Vibriofischer
Y-1, emits yellow light rather than the blue-green emission
typical of other luminous bacteria. The yellow emission has
been postulated previously to result from energy transfer from
an electronically excited species formed in the bacterial lucif-
erase-catalyzed reaction to a secondary emitter protein, termed
the yellow fluorescent protein (YFP). We report here the
purification of YFP to homogeneity without loss of the chro-
mophore. The protein was found to be a homodimer of Mr
22,000 subunits with one weakly bound FMN per subunit. The
FMN-protein complex was stabilized by 10% (vol/vol) glycerol
in the buffers, allowing purification ofthe active holo-YFP. The
protein migrated as a single spot with an isoelectric point of
=6.5 on two-dimensional polyacrylamide gel electrophoresis
and gave an N-terminal sequence of Met-Phe-Lys-Gly-Ile-Val-
Glu-Gly-Ile-Gly-Ile-Ile-Glu-Lys-Ile. Addition of purified YFP
to a reaction in which luciferase was supplied with FMNH2
(reduced FMN) by a NADH:FMN oxidoreductase resulted in a
dramatic enhancement in the intensity of bioluminescence and
an additional peak in the emission spectrum at about 534 nm.
The resulting bimodal bioluminescence emission spectrum had
peaks at 484 nm, apparently due to emission from the lucif-
erase-flavin complex, and at 534 nm, corresponding to the flu-
orescence emission maximum of YFP. This bimodal spectrum
closely matched the emission spectrum in vivo.
Light emission from bioluminescent bacteria is the result of
the action of the enzyme bacterial luciferase, a flavin
monooxygenase that catalyzes the following reaction:
FMNH2 + 02 + RCHO -- hv + FMN + H20 + RCOOH,
in which FMNH2 is reduced FMN and RCHO and RCOOH
are long-chain fatty aldehydes and acids, respectively (see
ref. 1 for a review). Two lines ofevidence have suggested that
the light emitted comes from the singlet excited state of an
enzyme-bound flavin intermediate formed in the luciferase
reaction for Vibrio harveyi, both in vivo and in vitro: (i) Cline
and Hastings found that several mutants of V. harveyi having
altered luciferase reaction kinetics also had altered biolumi-
nescence emission spectra that had been red-shifted as much
as 12-15 nm both in vivo and in vitro (2, 3), and (it) Mitchell
and Hastings showed that the spectrum of light emitted in
vitro is strongly shifted by alterations in the isoalloxazine
nucleus ofthe flavin (4). It has been suggested that the emitter
in the reaction catalyzed by the V. harveyi enzyme in vitro is
a carbon-4a-substituted flavin intermediate, possibly the
4a-hydroxyflavin (5-7).
Some strains of luminous bacteria have emission spectra in
vivo with Xmax shifted relative to the in vitro emission spectra
because of other proteins in the light-emitting system.
Terpstra reported a fluorescent material in crude extracts of
Photobacterium phosphoreum that stimulated the light reac-
tion in vitro (8, 9). P. phosphoreum and Photobacterium
leiognathi, which emit blue light (Xma,, = 478 nm), do so
because of a blue fluorescent protein ("lumazine protein")
whose chromophore was identified as 6,7-dimethyl-
ribityllumazine (10-14). Addition of lumazine protein to the
purified luciferases of P. phosphoreum or P. leiognathi
results in an apparent blue shift in the wavelength maximum
of the bioluminescence reaction, an observation that led to
the suggestion that the primary excited state in the bacterial
bioluminescence reaction might not be the flavin but rather
some other species of higher energy (1).
Most strains of Vibriofischeri emit light with a wavelength
maximum around 485 nm. However, one strain isolated by
Ruby and Nealson (15), designated Y-1, displays an emission
spectrum with a peak at 545 nm when grown at temperatures
below 220C, but emits at the usual 485 nm if grown at higher
temperatures. The striking difference in the color of emission
is shown in Fig. 1. The culture on the left is P. phosphoreum
(NCMB 844) and the culture on the right is V. fischeri strain
Y-1 (American Type Culture Collection 33715). In their
preliminary study of this system, Ruby and Nealson showed
that the luciferase from Y-1, like other bacterial luciferases,
catalyzes the emission of blue-green light (Xmax 484 nm)
(15). Y-1 was subsequently shown by Leisman and Nealson
to contain a yellow fluorescent protein (YFP) that, when
added to a Y-1 luciferase reaction with FMNH2 supplied by
NADH:FMN oxidoreductase, caused a dramatic increase in
the emission of light at 534 nm (17). This paper reports the
purification to homogeneity ofthe yellow fluorescent protein,
determination of its physical properties, and the optimum
conditions for yellow light emission.
METHODS
V. flscheri strain Y-1 (American Type Culture Collection
33715) was grown in 1.5 liters of NaCl complete medium at
18'C in 2.8-liter Fernbach flasks (18). The cells were grown
to an OD6w of 1.5, centrifuged at 14,300 x g for 30 min, and
stored at -20'C. Purification steps were conducted at 40C.
Frozen cells (about 150 g) were thawed and lysed by osmotic
shock in 600 ml of 10mM EDTA/1 mM dithiothreitol, pH 7.0,
as described (16). Lysis was usually complete within 30 min.
Cell debris was removed by centrifugation at 16,000 x g for
20 min, and the supernatant was subjected to ammonium
sulfate fractionation. The protein precipitating between 40%
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FIG. 1. Cultures ofP. phosphoreum (Left) and V.fischeri Y-1 (Right). Both cultures were grown at 180C in sodium chloride complete medium
(16). This photograph was taken in the dark without an external light source.
and 70% saturation was resuspended in and dialyzed against
30 mM sodium phosphate/1 mM EDTA/1 mM dithiothreitol,
pH 7.0. This step usually resulted in about 200 ml ofa solution
containing 10-20 mg of protein per ml.
One gram of DEAE-cellulose (DE52, Whatman), previ-
ously equilibrated with 30 mM sodium phosphate/1 mM
EDTA/1 mM dithiothreitol, pH 7.0, was added per 100 mg of
protein, and the suspension was stirred for 45 min. The
filtrate (unbound material, including YFP) was concentrated,
if necessary, to -20 mg per ml by vacuum dialysis. Fifteen
milliliters (about 1/10th of the total) was applied to an
Ultrogel AcA 54 column (80 cm x 5 cm) and eluted with 30
mM sodium phosphate/1 mM EDTA/1 mM dithiothreitol/
2% glycerol, pH 7.0. The YFP fraction, typically 100 ml, was
pooled and concentrated to 5 ml by placing it in dialysis
tubing with a molecular weight cutoff of 3500 and embedding
it in a mound of finely powdered sucrose. Pools from these
Ultrogel separations were combined. This sample was dia-
lyzed vs. 30 mM sodium phosphate/1 mM EDTA/1 mM
dithiothreitol/10% glycerol, pH 7.0, and applied to a column
of DEAE-Sephacel (15 cm x 2.5 cm) previously equilibrated
with the same buffer. After loading was complete, a linear
gradient was started between the initial buffer and 200 mM
sodium phosphate (pH 7.0) (150 ml each); both buffers
contained 1 mM EDTA, 1 mM dithiothreitol, and 10%
glycerol. Homogeneous YFP was eluted at about 50 mM
sodium phosphate. In the early stages of purification, YFP-
containing fractions were detected by fluorescence excited
with a hand-held mercury vapor lamp. In the later stages of
purification, the YFP-containing fractions were located by
fluorescence, and the YFP content was determined by
absorbance spectra, fluorescence spectra, the coupled bio-
luminescence assay described below, and NaDodSO4 gel
electrophoresis.
Luciferase was prepared from a side fraction of the YFP
preparation. The DE52 resin through which the YFP prepa-
ration had been filtered was washed once with 0.25 M
NaCl/30 mM sodium phosphate/1 mM dithiothreitol/1 mM
EDTA, pH 7.0. This resin was filtered and resuspended in 2
M NaCl/30 mM sodium phosphate/1 mM dithiothreitol/1
mM EDTA, pH 7.0, and stirred for 30 min. The resin was
filtered, and the filtrate, containing luciferase and NADH:
FMN oxidoreductase, was dialyzed vs. 100 mM sodium
phosphate/0.5 mM dithiothreitol, pH 7.0. The luciferase was
further purified by the affinity chromatography method of
Holzman and Baldwin (19).
Absorbance spectra were recorded on a Kontron Uvikon
810 spectrophotometer. Fluorescence and bioluminescence
spectra were recorded on an SLM model 8000 spectrofluo-
rometer. Protein determinations were performed with the
Bio-Rad protein assay with carbonic anhydrase as a standard.
Protein determinations with the Bio-Rad assay were found to
agree with values obtained by the Lowry method using the
same standard (20) and with values from amino acid analysis
of samples that had been hydrolyzed in vacuo in 6 M HCO for
24 hr at 110°C. N-terminal sequence analysis was carried out
by Edman degradation using a Beckman sequencer; phenyl-
thiohydantoin amino acids were determined by HPLC meth-
ods (21).
Luciferase activity was determined by the FMNH2 injec-
tion method (16). Bioluminescence emission spectra were
recorded from reactions in which FMNH2 was supplied to the
luciferase with the NADH:FMN oxidoreductase-coupled
assay (16) with the following modifications: total volume was
600 Al in buffer containing 100 mM sodium phosphate, 1%
bovine serum albumin, 185 ,M NADH, 6 AM FMN, and
0.008% aldehyde (from a 1% sonicated suspension in H20).
Typically an assay contained 0.8 ,uM luciferase and was
carried out at pH 7.0. Luciferase preparations contained
sufficient NADH:FMN oxidoreductase to maintain FMNH2
production. The order of addition was: 1, buffer; 2, aldehyde;
3, luciferase; 4, YFP in Ultrogel column elution buffer (or
Ultrogel elution buffer containing no protein); and 5, NADH.
NADH was added from a freshly prepared stock of 11.1 mM
NADH in 100 ,M Tris*HCl (pH 8.0). Total light was recorded
with a photomultiplier photometer (22); bioluminescence
emission spectra were recorded in the SLM fluorometer by
monitoring the emission slit with the excitation lamp turned
off. The intensity of bioluminescence emitted at 534 nm was
divided by the intensity at 484 nm to give a ratio called the
yellow/blue (Y/B) value, allowing comparison of the relative
amount of yellow light being produced in different assays.
To determine the identity of the flavin, three experiments
were performed. For the first, purified YFP (about 10 nmol
of protein-bound flavin) was dialyzed vs. water at 4°C with
four changes at 30-min intervals to remove buffer and
additives. It was boiled for 15 min to denature the protein and
was centrifuged for 5 min at 14,000 x g in an Eppendorf
Microfuge. The supernatant was lyophilized to dryness and
then redissolved in 200 ,ul of water. This extract was applied
to a C18 reversed-phase HPLC column by using the system
described by Light et al. (23). For the second and third
experiments, the YFP sample was not dialyzed before dena-
turation, and each was started with about 3 nmol of protein-
bound flavin. In one experiment the flavin-containing extract
was exposed to Naja naja venom (Sigma) to look for any
change in fluorescence properties signifying hydrolysis of
FAD to FMN (24). In the other, the flavin-containing extract
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was tested as a substrate for the luciferase-FMN oxidore-
ductase-coupled assay described above.
NaDodSO4/polyacrylamide gel electrophoresis was per-
formed as described by Laemmli (25) on slabs of 12%
polyacrylamide. Gels were stained by immersion in 0.05%
Coomassie blue R-250 in 10% isopropanol, 10% acetic acid,
and destained with 10% isopropanol, 10% acetic acid. Two-
dimensional electrophoresis was carried out as described by
O'Farrell (26).
RESULTS AND DISCUSSION
Isolation of YFP. YFP was purified by a simple four-step
procedure consisting of ammonium sulfate fractionation,
DE52 (DEAE-cellulose) batch extraction, Ultrogel AcA 54
chromatography, and DEAE-Sephacel chromatography as
described. Purification parameters for a typical preparation
are presented in Table 1. YFP purity was estimated by
spectral parameters, by the intensity of bands appearing on
NaDodSO4 gels, by the intensity and number of spots on
two-dimensional gels, and by N-terminal amino acid se-
quence. Contaminating flavoproteins that interfere with the
absorbance spectrum were removed by the DE52 extraction.
The DE52 filtrate contained two fluorescent species, YFP
and a contaminating fluorophore with an emission km,,, at 460
nm; the two were resolved on the Ultrogel column. The
pooled YFP-containing fractions from the Ultrogel column
had several bands appearing near Mr 20,000-25,000 on
NaDodSO4 gels. Of particular interest was a protein that
comigrated with YFP on NaDodSO4 gels. It first was detect-
ed in a fraction from an Ultrogel column run without a prior
DEAE-cellulose extraction step; the column fraction gave a
single band on NaDodSO4 gels but was shown by N-terminal
amino acid sequence analysis to be heterogeneous, and the
contaminating protein was subsequently resolved from YFP
on two-dimensional gels of the Ultrogel eluate. After the
DE52 batch extraction step was added to the protocol, the
second spot no longer appeared on two-dimensional gels of
Ultrogel or DEAE-Sephacel eluates. Inclusion of glycerol in
the elution and dialysis buffers was essential to prevent
dissociation of the fluorophore from the protein during
purification, a difficulty that has plagued attempts of others
to purify the holoprotein (27). The spectral parameters of the
DEAE-Sephacel eluate presented in Table 1 are for the
holoprotein; the protein did not lose its yellow color or yellow
fluorescence upon dialysis or gel filtration when the buffers
contained glycerol.
The most difficult contaminant to remove was a c-type
cytochrome. After the DE52 batch step, the visible spectra of
the protein samples appeared to be mixtures ofa flavoprotein
and a c-type cytochrome. The DE52 filtrate displayed a
strong cytochrome c spectrum with a small amount of species
that absorbed light in the 430-470-nm range. The Ultrogel
eluate showed a distinct flavin spectrum (absorbance peaks
at 380 and 454 nm) with a small amount of contaminating
cytochrome (peaks at 418 and 552 nm), and the DEAE-
Table 1. Purification parameters for YFP isolation
Ratios
A415 A2,0 mg/ml* Protein,*
Sample A445 A445 A5 mg
(NH4)2SO4 precipitate 1.7 120.4 26.1 6525
DEAE-cellulose filtrate 1.7 37.0 16.3 2445
Ultrogel eluate 2.1 13.6 5.9 528
DEAE-Sephacel eluate 0.7 6.4 2.7 280
Data were compiled from a preparation started with about 150 g of
cells.
*Protein concentrations were determined by Bio-Rad assay.
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FIG. 2. Absorbance spectrum of the fluorescent fraction eluted
from DEAE-Sephacel column. The sample is in 50mM phosphate/i
mM dithiothreitol/1 mM EDTA/10% glycerol, pH 7.0, and contains
-30 ,ug of protein per ml. The spectrum was taken at room
temperature.
Sephacel eluate showed a clean flavin spectrum, with no
apparent contribution from the cytochrome (Fig. 2). The
absorbance maxima are at 382 nm and 454 nm, typical for a
flavoprotein. Fig. 3 shows a NaDodSO4/polyacrylamide gel
(12%) of typical elution fractions from DEAE-Sephacel.
Properties of YFP. Estimates of molecular weight were
made by gel filtration on Ultrogel AcA 54 and by mobility on
denaturing polyacrylamide gels. Compared to standard pro-
teins, YFP eluted from the molecular sieve column at a
volume appropriate for a protein of Mr 43,600, whereas on
denaturing NaDodSO4/polyacrylamide gels, it displayed an
apparent Mr of 22,000. Edman degradation of the protein
demonstrated a unique N-terminal amino acid sequence (see
below). These data suggest that YFP exists as a dimer of
identical subunits.
The ligand bound to YFP was clearly a flavin, exhibiting
absorbance and fluorescence characteristics of protein-
bound flavin. The flavin was shown to be FMN by three
methods. First, it was eluted with a retention time identical
to that of standard FMN on HPLC (23). Second, it did not
display any change in fluorescence properties upon incuba-
tion with N. naja venom, which would hydrolyze FAD to the
more fluorescent FMN (24). Finally, at a concentration of 1.2
,uM, it was able to sustain light production in the luciferase-
FMN oxidoreductase system without addition of any other
source of flavin, ruling out FAD and riboflavin (4). Based on
I-
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FIG. 3. NaDodSO4/polyacrylamide gel after electrophoresis of
consecutive samples of YFP eluted from DEAE-Sephacel column.
The lane on the far left contains the standards bovine serum albumin
(M, 66,000), ovalbumin (Mr 45,000), glyceraldehyde-3-phosphate
dehydrogenase (Mr 36,000), carbonic anhydrase (Mr 29,000), tryp-
sinogen (Mr 24,000), soybean trypsin inhibitor (Mr 20,100), and
a-lactalbumin (Mr 14,200). Electrophoresis and staining were carried
out as described. The anode is at the bottom of the gel.
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FIG. 4. Bioluminescence assays of luciferase in the presence and
absence of YFP. Assays were carried out as described (with
1-decanal as the aldehyde) at 6°C. Curves: 1, spectrum of V. fischeri
Y-1 luciferase emission with 0.83 ,uM luciferase; 2, spectrum run with
the same amount of luciferase in the presence of 2.5 ,uM YFP; 3,
fluorescence emission spectrum of YFP obtained by irradiating a
solution of 2.4 /LM YFP in 30 mM sodium phosphate/1 mM
dithiothreitol/1 mM EDTA/10% glycerol, pH 7.0, at 380 nm.
the extinction coefficient at 454 nm for YFP [11,600 M-1
cm-1, determined by using the method described by Thorpe
et al. (28)] and protein concentrations determined by the
Bio-Rad assay, the DEAE-Sephacel eluate contained 0.77
FMN molecule per 22,000 daltons of protein, suggesting that
each subunit of YFP contains one FMN molecule.
Purified YFP was subjected to Edman degradation. The
N-terminal sequence was determined to be the following:
Met-Phe-Lys-Gly-Ile-Val-Glu-Gly-Ile-Gly-Ile-Ile-Glu-Lys-
Ile.
Alteration of Luciferase Emission by YFP. The ability of
YFP to alter the color of the light emitted during a luciferase
assay is modified by several factors (17). The most striking of
these factors is temperature: cells grown above 22°C emit
blue-green light and cells grown at 18°C or lower tempera-
tures emit yellow light (15). The emission spectra of lucifer-
ase reactions in the presence of various purified protein
components of this system are shown in Figs. 4 and 5. All of
the bioluminescence spectra in these figures were carried out
at the same voltages so that the ordinates are directly
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comparable. The addition of YFP to a luciferase-FMN
oxidoreductase assay resulted in a 3.6-fold increase in the
intensity of total light emitted (Fig. 4). The appearance of a
new peak at 534 nm shifted the Y/B (534 nm/484 nm) value
from 0.64 to 1.26. When YFP was added to the assay mixture
in the absence of luciferase, no emission was detected by the
fluorometer. Superimposed on the bioluminescence spectra
of Fig. 4 is a fluorescence emission spectrum of YFP to
demonstrate the identity of the fluorescence emission max-
imum of YFP with the yellow-shifted bioluminescence max-
imum.
The effect of YFP on the bioluminescence emission of
luciferase is dependent on the relative concentrations ofYFP
and luciferase (Fig. 5). At lower luciferase concentrations
(Fig. SA), the Y/B value varied more upon addition of
increasing levels of YFP, as the effect of YFP on intensity of
blue emission seemed to be saturated at a concentration
lower than its effect on intensity of yellow emission. With a
higher luciferase concentration (Fig. SB), both blue and
yellow emission increased upon each addition of YFP.
An increase in temperature from 60C to 21'C resulted in a
2.2-fold increase in the intensity of light emission from a
luciferase/YFP reaction. An increase in total light intensity
was expected since the total intensity of the reaction cata-
lyzed by luciferase alone increased 1.8-fold with the same
increase in temperature. Furthermore, the color shift seen in
vivo (15) was also seen in vitro: in the presence of YFP, the
Y/B value at 21'C was 0.61, and the ratio at 60C was 1.12.
The Y/B value varied with pH as well as with temperature.
At 60C and pH 7.4, the Y/B value was 0.75 and at pH 7.0 it
was 0.95; total light intensity at pH 7.4 was 1.5-fold greater
than at pH 7.0 (data not shown). Over the greater pH range
of 6.2-8.4, the total light intensity increased and reached a
peak at about pH 7.4, declining at higher pH values. When
assayed in the absence of YFP, the total light intensity of the
luciferase reaction is essentially constant between pH 7.0 and
pH 7.4 (29); thus some of the increase between 7.0 and 7.4
must be due to the effect of YFP.
CONCLUSION
The mechanism ofenergy transfer between luciferase and the
lumazine protein, extensively studied by Lee and his co-
workers, seems to depend on an interaction between the two
proteins (30, 31). We have not yet performed experiments to
see if a physical interaction between YFP and luciferase can
Wavelength, nm Wavelength, nm
FIG. 5. Effect of luciferase and YFP concentrations on YFP-induced shift of bioluminescence intensity and color. (A) Spectra obtained with
0.3 ALM luciferase. (B) Spectra obtained with 0.8 ,uM luciferase. All spectra were obtained with the luciferase-NADH:FMN oxidoreductase-
coupled assay as described (with 1-dodecanal) at 6°C. Curves in A and B: 1, luciferase emission in the absence of YFP; 2, luciferase emission
with 0.83 ,uM YFP; 3, with 1.25 /LM YFP; 4, with 1.67 jM YFP; 5, with 2.5 ,uM YFP.
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be demonstrated. The two fluorescent proteins are similar in
certain respects (subunit molecular weight, ability to enhance
luciferase emission), but there is an important difference
between them: the lumazine protein effects a transfer leading
to emission of light of higher energy than is emitted by
luciferase alone (478 nm vs. 490 nm) and YFP effects an
energy transfer causing light of lower energy to be emitted
(534 nm vs. 484 nm). This difference should allow the two
auxiliary proteins to be complementary probes in investiga-
tions of the mechanism of energy transfer and the nature of
the primary excited species in the bioluminescence reaction.
The method reported here for purification ofYFP in a stable
form establishes the possibility of its use in such studies.
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